Endoscopy 2020; 52(06): 474-482
DOI: 10.1055/a-1120-8498
Innovations and brief communications

A new 12-French plastic stent for unresectable distal malignant biliary obstruction

Pierre H. Deprez
1   Department of Gastroenterology. Cliniques universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium
,
Tom G. Moreels
1   Department of Gastroenterology. Cliniques universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium
,
Tarik Aouattah
1   Department of Gastroenterology. Cliniques universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium
,
Hubert Piessevaux
1   Department of Gastroenterology. Cliniques universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium
,
Enrique Pérez-Cuadrado-Robles
1   Department of Gastroenterology. Cliniques universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium
2   Department of Gastroenterology. Hôpital Européen Georges-Pompidou, Paris, France
› Author Affiliations


Abstract

Background Self-expanding metal stents (SEMSs) are recommended in unresectable distal malignant biliary obstruction. However, problems with dysfunction and migration of these stents are not negligible. We aimed to investigate the effectiveness and safety of a new 12-Fr plastic stent.

Methods In an observational, prospective study, all consecutive patients who underwent biliary stenting with the 12-Fr stent were considered (index group). Referent groups were a historical cohort, matched by sex, etiology, and metastatic status, including patients with 10-Fr plastic stents and with fully covered and uncovered SEMSs (FCSEMSs and UCSEMSs). Outcomes were stent patency, recurrent biliary obstruction (RBO), technical success, 30-day mortality and adverse events. A post-procedure examination of removed stents was done.

Results 72 patients (median age 66, range 32 – 94 years, 50 % men) were included (24 index, 48 referents). There were no differences in median stent patency time (P = 0.684). RBO was significantly lower with the 12-Fr compared with the 10-Fr profile stent (50 % vs. 81.3 %, P = 0.04), but no difference was found compared with the FCSEMSs (50 % vs. 43.8 %, P = 0.698). Technical success was 100 %, with no differences in 30-day mortality P = 0.105). The adverse events rate was 4.2 % for both groups (index n = 1, referents n = 2). Of 11 removed 12-Fr plastic stents suspected to be dysfunctional, 7 (64 %) were still patent.

Conclusions This new 12-Fr plastic stent could be an effective and cheaper alternative to SEMSs in distal malignant biliary obstruction.



Publication History

Received: 19 January 2020

Accepted: 24 January 2020

Article published online:
30 March 2020

© Georg Thieme Verlag KG
Stuttgart · New York

 
  • References

  • 1 Smith AG, Dowset JF, Rassell RCG. et al. Randomized trial of endoscopic stenting versus surgical bypass in malignant low bile duct obstruction. Lancet 1994; 344: 1655-1660
  • 2 Isayama H, Komatsu Y, Tsujino T. et al. Polyurethane covered metal stent for management of distal malignant biliary obstruction. Gastrointest Endosc 2002; 55: 366-370
  • 3 Isayama H, Nakai Y, Togawa O. et al. Covered metallic stents in the management of malignant and benign pancreatobiliary strictures. J Hepatobiliary Pancreat Surg 2009; 16: 624-627
  • 4 Tringali A, Mutignani M, Perri V. et al. A prospective, randomized multicenter trial comparing Double Layer and polyethylene stents for malignant distal common bile duct strictures. Endoscopy 2003; 35: 992-997
  • 5 Weickert U, Venzke T, König J. et al. Why do bilioduodenal plastic stents become occluded? A clinical and pathological investigation on 100 consecutive patients. Endoscopy 2001; 33: 786-790
  • 6 Pereira-Lima JC, Jakobs R, Maier M. et al. Endoscopic biliary stenting for the palliation of pancreatic cancer: results, survival predictive factors, and comparison of 10-Fr with 11.5-Fr gauge stents. Am J Gastroenterol 1996; 91: 2179-2184
  • 7 Dumonceau JM, Tringali A, Papanikolaou IS. et al. Endoscopic biliary stenting: indications, choice of stents, and results: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline – Updated October 2017. Endoscopy 2018; 50: 910-930
  • 8 Zorrón Pu L, de Moura EG, Bernardo WM. et al. Endoscopic stenting for inoperable malignant biliary obstruction: A systematic review and meta-analysis. World J Gastroenterol 2015; 21: 13374-13385
  • 9 Almadi MA, Barkun A, Martel M. Plastic vs. self-expandable metal stents for palliation in malignant biliary obstruction: a series of meta-analyses. Am J Gastroenterol 2017; 112: 260-273
  • 10 Isayama H, Nakai Y, Kogure H. et al. Biliary self-expandable metallic stent for unresectable malignant distal biliary obstruction: which is better: covered or uncovered?. Dig Endosc 2013; 25 (Suppl. 02) 71-74
  • 11 Tringali A, Hassan C, Rota M. et al. Covered vs. uncovered self-expandable metal stents for malignant distal biliary strictures: a systematic review and meta-analysis. Endoscopy 2018; 50: 631-641
  • 12 Yokota Y, Fukasawa M, Takano S. et al. Partially covered metal stents have longer patency than uncovered and fully covered metal stents in the management of distal malignant biliary obstruction: a retrospective study. BMC Gastroenterol 2017; 11: 105
  • 13 Kim JY, Ko GB, Lee TH. et al. Partially covered metal stents may not prolong stent patency compared to uncovered stents in unresectable malignant distal biliary obstruction. Gut Liver 2017; 15: 440-446
  • 14 Chandrasekhara V, Khashab MA. ASGE Standards of Practice Committee. et al. Adverse events associated with ERCP. Gastrointest Endosc 2017; 85: 32-47
  • 15 Naonaga E. The experimental studies on the correlations of internal pressure between bile duct and duodenum. Jpn J Gastroenterol 1960; 57: 1457-1480 https://doi.org/10.11405/nisshoshi1946.57.11_1457
  • 16 Conio M, Mangiavillano B, Caruso A. et al. Covered versus uncovered self-expandable metal stent for palliation of primary malignant extrahepatic biliary strictures: a randomized multicenter study. Gastrointest Endosc 2018; 88: 283-291.e3
  • 17 Kullman E, Frozanpor F, Söderlund C. et al. Covered versus uncovered self-expandable nitinol stents in the palliative treatment of malignant distal biliary obstruction: results from a randomized, multicenter study. Gastrointest Endosc 2010; 72: 915-23
  • 18 Hamada T, Isayama H, Nakai Y. et al. Antireflux covered metal stent for nonresectable distal malignant biliary obstruction: Multicenter randomized controlled trial. Dig Endosc 2019; 31: 566-574
  • 19 Kawashima H, Hashimoto S, Ohno E. et al. Comparison of 8- and 10-mm diameter fully covered self-expandable metal stents: A multicenter prospective study in patients with distal malignant biliary obstruction. Dig Endosc 2019; 31: 439-447
  • 20 Sripongpun P, Attasaranya S, Chamroonkul N. et al. Simple clinical score to predict 24-week survival times in patients with inoperable malignant distal biliary obstruction as a tool for selecting palliative metallic or plastic stents. J Gastrointest Cancer 2018; 49: 138-143
  • 21 Sawas T, Al Halabi S, Parsi MA. et al. Self-expandable metal stents versus plastic stents for malignant biliary obstruction: a meta-analysis. Gastrointest Endosc 2015; 82: 256-267.e7
  • 22 Yuan TW, Liu HQ, Wang SB. et al. Comparison of plastic stents with self-expandable metal stents in palliative treatment of malignant biliary obstruction: a meta-analysis. Eur Rev Med Pharmacol Sci 2017; 21: 2847-2857
  • 23 Wagh MS, de Bellis M, Fogel EL. et al. Multicenter randomized trial of 10-Fr versus 11.5-Fr plastic stents for malignant biliary obstruction. Diagn Ther Endosc 2013; 2013: 891915
  • 24 Siegel JH, Pullano W, Kodsi B. et al. Optimal palliation of malignant bile duct obstruction: experience with endoscopic 12 French prostheses. Endoscopy 1988; 20: 137-41
  • 25 Matsumoto K, Takeda Y, Onoyama T. et al. Endoscopic treatment for distal malignant biliary obstruction. Ann Transl Med 2017; 5: 190